Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification.
| Excerpt | Reference |
|---|
| "Calciphylaxis is a local tissue calcific reaction at the site of an injection of challenger substance given a critical time period after the oral administration of a sensitizer substance such as dihydrotachysterol (DHT), vitamin D or parathormone." | ( McClure, J; Miller, S; Vernon-Roberts, E, 1984) |
| "Calciphylaxis is a rare disease associated with hemodialysis or transplantation, high parathyroid hormone values, and increased serum calcium x phosphate (Ca x P) product." | ( Fine, A; Fleming, S; Leslie, W, 1995) |
| "Calciphylaxis is a rare and life-threatening complication that is estimated to occur in 1% of patients with ESRD each year." | ( Budisavljevic, MN; Cheek, D; Ploth, DW, 1996) |
| "Calciphylaxis is a rare late complication in patients with advanced, often end-stage renal failure." | ( Dannenberg, L; Göbel, U; Henschel, A; Ott, A; Schultz-Ehrenburg, U, 1999) |
| "Calciphylaxis is a rapidly developing, fatal process of vascular calcium deposition with prominent cutaneous manifestation." | ( Hanaoka, M; Higashihara, M; Kobayashi, Y; Matsuo, T; Nagaoka, T; Saegusa, N; Tamura, M; Tsukamoto, Y; Yokoyama, H, 2001) |
| "Calciphylaxis is a severe complication of chronic renal failure, confined almost exclusively to patients on dialysis therapy." | ( Cosio, FG; Middendorf, DF; Singh, I; Voroshilova, O; Wilmer, WA, 2001) |
| "Calciphylaxis is associated with a very high mortality." | ( Davis, CL; Gillen, D; Johnson, RJ; Mazhar, AR; Ryan, MJ; Stehman-Breen, CO; Stivelman, JC, 2001) |
| "Calciphylaxis is a rare disorder of small-vessel calcification and cutaneous infarction associated with chronic renal failure." | ( Kaur, JS; Pfeifer, EA; Riegert-Johnson, DL, 2001) |
| "Calciphylaxis is an uncommon but serious disease process that affects mainly patients with advanced renal failure." | ( Barrientos, A; Coronel, F; López-Bran, E; Marrón, B, 2001) |
| "Calciphylaxis is a rare complication in patients undergoing hemodialysis." | ( Friedman, SG, 2002) |
| "Calciphylaxis is an uncommon condition usually seen in patients with end-stage renal disease." | ( Jacobsohn, HA; Jacobsohn, KM; Jenkins, PG, 2002) |
| "Calciphylaxis is a rare syndrome developing predominantly in female patients suffering from end-stage renal disease (ESRD) with secondary hyperparathyroidism." | ( Graefe, T; Tittelbach, J; Wollina, U, 2001) |
| "Calciphylaxis is a rare and potentially fatal complication of end stage renal disease (ESRD) and secondary hyperparathyroidism associated with abnormal calcium metabolism." | ( Bliss, DE, 2002) |
| "Calciphylaxis is a relatively rare, but horribly disfiguring, skin condition that is most often associated with end-stage renal disease and long-term dialysis." | ( Beitz, JM, 2003) |
| "Calciphylaxis is a dreaded complication of renal failure characterized by nodular subcutaneous calcification and painful tissue necrosis often leading to ulceration, secondary infection, and high mortality rates." | ( Cicone, JS; Embert, CD; Petronis, JB; Spector, DA, 2004) |
| "Breast calciphylaxis is a rare disease clinically characterized by progressive tissular necrosis with secondary cutaneous ulceration and by vascular calcification and thrombosis." | ( Buxant, F; Jedwab, J; Noël, JC, 2004) |
| "Calciphylaxis is a condition with a generally poor prognosis about which relatively little is known." | ( Beus, KS; Stack, BC, 2004) |
| "Calciphylaxis is a small-vessel disease associated with renal failure." | ( Horishita, T; Minami, K; Ogata, J; Sata, T, 2004) |
| "Calciphylaxis is associated with medial arteriolar vascular calcification and results in ischemic subcutaneous necrosis with vulnerable skin ulcerations and high mortality." | ( Hayden, MR; Khanna, R; Kolb, L; Sowers, JR; Tyagi, SC, 2005) |
| "Calciphylaxis is a rare, but life-threatening complication of end-stage renal disease (ESRD) that has been reported mostly in adult patients." | ( Bloom, DA; Imam, AA; Kapur, G; Mattoo, TK; Valentini, RP, 2005) |
| "Calciphylaxis is a highly morbid syndrome of vascular calcification and skin necrosis, the pathophysiology of which remains largely elusive." | ( Line, BR; Norris, B; Vaysman, V, 2005) |
| "Calciphylaxis is a very uncommon and severe disease which mainly appears in patients with chronic renal insufficiency." | ( Gille, J; Kaufmann, R; Meissner, M, 2006) |
| "When calciphylaxis is complicated with advanced renal hyperparathyroidism (HPT), parathyroidectomy (PTX) should be performed promptly." | ( Hirakata, H; Iida, M; Maeda, H; Taniguchi, M; Tokumoto, M; Tsuruya, K; Yotsueda, H, 2007) |
| "Calciphylaxis is a relatively rare disorder associated with calcification of small- and medium-sized blood vessels, progressive ischemic skin necrosis, and ulcerations." | ( Amin, MB; Bosler, DS; Gulli, F; Malhotra, RK, 2007) |
| "Calciphylaxis is a rare condition affecting patients suffering from end-stage renal failure, characterised by cutaneous ischaemia and necrosis." | ( Bubtana, AJ; Hutchison, AJ; Mitra, S; Mohammed, IA; Sekar, V, 2008) |
| "Calciphylaxis is a rare, but potentially life-threatening condition usually observed in patients with end-stage chronic renal disease and characterized by small- and medium-sized blood vessel calcification leading to tissue ischemia." | ( Bonfigli, F; Giansante, C; Gottardi, C; Padovan, C; Trevisan, G; Ulessi, B, 2008) |
| "Calciphylaxis is a rare necrotizing calcifying arteriolopathy, with a poor prognosis, for which there is currently no effective treatment." | ( Allot, V; Bonnetblanc, JM; Durox, H; Labrousse, F; Pommepuy, I; Prey, S; Roux, C; Salem, A; Sparsa, A, 2009) |
| "Calciphylaxis is a rare, life-threatening cause of skin necrosis." | ( Hackett, BC; McAleer, MA; O'Donnell, BF; Powell, FC; Sheehan, G, 2009) |
| "Calciphylaxis is defined by the presence of calcium deposits within the wall of small and medium-sized vessels." | ( Daudén, E; Oñate, MJ, 2008) |
| "As the treatment of calciphylaxis is mainly empirical and controversial, we decided to administer cinacalcet with paricalcitol for the control of hyperparathyroidism and sodium thiosulfate to improve the calcification of the arterioles." | ( Agroyannis, B; Agroyannis, I; Gombou, A; Griveas, I; Kyritsis, I; Retsa, K, 2008) |
| "Calciphylaxis is a rare and debilitating vasculopathy predominantly seen in patients with renal failure." | ( Chan, MR; Hinshaw, M; Jaffery, JB; Yevzlin, AS, 2008) |
| "Calciphylaxis is a rare complication that occurs in 1% of patients with end-stage renal disease (ESRD) each year." | ( Almafragi, A; Dujardin, K; Vandorpe, J, 2009) |
| "Calciphylaxis is an infrequent but severe entity found in chronic dialysis patients." | ( Algranati, L; Enz, P; Galimberti, R; Garfi, L; Gelman, R; Giuseppe, LD; Kowalczuk, A; Lizarraga, A; Musso, CG; Vidal, F, 2009) |
| "Calciphylaxis is a rare, usually fatal vasculopathic disorder characterized by cutaneous ischemia and necrosis due to calcification of arterioles." | ( Banerjee, C; Holm, JR; Lahey, MJ; Stevens, SM; Woller, SC, 2010) |
| "Penile calciphylaxis is very rare but has a mortality rate of 69% within 6 months." | ( Djebali, D; Gini, MB; Ranade, A; Sandhu, G; Smith, S, 2012) |
| "Calciphylaxis is a rare complication of chronic renal failure mostly with poor prognosis." | ( Sulková, SD; Válek, M, 2010) |
| "Calciphylaxis is a severe "vascular ossification-calcification," associated with a very high mortality rate that involves arterial wall, venular wall, and nerves resulting in ischemia and necrosis of skin, subcutaneous fat, visceral organs, and skeletal muscles." | ( Di Raimondo, D; La Placa, S; Li Vecchi, M; Licata, G; Miceli, S; Milio, G; Pinto, A; Tuttolomondo, A, 2011) |
| "Calciphylaxis is a rare condition with dismal prognosis that affects patients with ESRD." | ( Landis, M; Moe, SM; Noureddine, L; Patel, N, 2011) |
| "Cutaneous calciphylaxis is a potentially fatal condition characterized by calcium deposition in dermal arterioles and the subsequent development of livedo reticularis, plaques, and extremely painful ulcers." | ( Amerio, P; Auriemma, M; Bonomini, M; Caponio, C; Carbone, A; Cupaiolo, A; De Simone, C; Di Liberato, L; Tulli, A, 2011) |
| "Calciphylaxis is a rare but life-threatening disease characterized by deposition of calcium within small and medium sized vessels, with subsequent thrombosis, cutaneous ischemia, and necrosis." | ( Barr, KL; Onofiok, E; Sivamani, RK, 2011) |
| "Calciphylaxis is a rare disease primarily affecting patients dependent on dialysis." | ( Heiro, M; Hohenthal, U; Koivuviita, N; Mäkelä, L; Manner, I; Metsärinne, K; Tertti, R, 2011) |
| "Calciphylaxis is a frequent entity in patients with chronic renal failure of diverse etiology." | ( Aliaga, LG; Barreira, JC, 2012) |
| "Calciphylaxis is a rare disorder characterized by painful skin necrosis and calcification of small vessels which is seen mainly in the dialysis population." | ( Naugler, W; Wichienkuer, P; Wusirika, R, 2011) |
| "Calciphylaxis is still an incompletely understood rare disease, which most often affects people on haemodialysis." | ( Brandenburg, VM; Ketteler, M; Kramann, R; Specht, P, 2012) |
| "Calciphylaxis is a rare and potentially life-threatening condition." | ( Merchant, W; Oliphant, T; Shareef, M; Smith, VM; Wilkinson, SM, 2012) |
| "Calciphylaxis is a life-threatening complication in patients with end-stage renal disease (ESRD)." | ( Auinger, M; König, M; Lhotta, K; Lingenhel, G; Rudnicki, M; Salmhofer, H; Schilcher, G; Vychytil, A; Wallner, M; Zitt, E, 2013) |
| "Calciphylaxis is a rare and life-threatening disease characterized by cutaneous necrosis and vascular calcification." | ( Arakaki, RY; Hoang, MP; Kroshinsky, D; Mochel, MC; Wang, G, 2013) |
| "Calciphylaxis is a relatively rare disease, observed mainly in patients on dialysis, associated with high mortality rates, and characterized by painful skin ulceration." | ( Hayashi, M, 2013) |
| "Calciphylaxis is an uncommon and often under diagnosed condition affecting patients undergoing chronic dialysis." | ( Burnie, R; Javaid, MM; Smail, S, 2013) |
| "Calciphylaxis is a rare life-threatening form of skin necrosis." | ( Brais, R; Deegan, P; Hafiji, J; Norris, P, 2013) |
| "Calciphylaxis is a metastatic calcification-induced vasculopathy that results in the occlusion of small blood vessels." | ( Castellanos, EH; Dahir, KM; McGirt, LY; Ning, MS, 2013) |
| "Calciphylaxis is a potentially fatal disorder of abnormal calcium deposition." | ( Bis, S; Kroshinsky, D; Nigwekar, SU; Sise, M; Smith, GP; Steele, D; Strazzula, L; Tsiaras, W, 2013) |
| "Calciphylaxis is a rare cutaneous disorder, characterized by vascular calcification and progressive skin necrosis, not yet described in cats." | ( Er, E; Reinacher, M; Thom, N, 2013) |
| "Calciphylaxis is a rare, yet life-threatening disease mainly occurring in dialysis patients." | ( Berr, F; Fend, F; Franzen, M; Hauser-Kronberger, C; Heemann, U; Hitzl, W; Koller, J; Kreymann, B; Salmhofer, H; Schmaderer, C, 2013) |
| "Calciphylaxis is a rare condition seen mostly in patients with chronic renal disease and secondary hyperparathyroidism who develop painful skin lesions and myopathy secondary to extensive small vessel calcification, which leads to tissue ischemia." | ( Motiwala, R; Sejdiu, F; Shin, S; Stavros, K; Zhou, L, 2014) |
| "Calciphylaxis is characterized by calcification and thrombosis of arteries resulting in ischemic necrosis of predominantly skin and subcutaneous tissue." | ( Asif, A; Goez-Gutierrez, E; Gonzalez-Suarez, M; Nayer, A; Rosenberg, AE; Salman, LH; Virmani, S, 2014) |
| "Calciphylaxis is a rare and life-threatening disorder associated with a mortality of 60-80%." | ( Borges, L; Cássio, I; Dias, E; Rosa, P, 2014) |
| "AbstractBackground:Calciphylaxis is a life-threatening condition traditionally observed in patients with end-stage renal disease." | ( Fernandes, C; Hanna, D; Maynard, B, 2014) |
| "Calciphylaxis is a rare and severe disease with an annual incidence of around 1 % in dialysis patients." | ( Aoun, A; Banydeen, R; Baubion, E; Derancourt, C; Djiconkpode, I; Dueymes, JM; Ekindi, N; Quist, D; Riaux, A; Sadreux, T; Ureña-Torres, P, 2014) |
| "Calciphylaxis is a rare cause of skin ulcerations and necrosis in patients with both normal renal and parathyroid function." | ( Arnault, JP; Chaby, G; Chatelain, D; Dadban, A; Dhaille, F; Dhillies, AS; Lok, C; Lombart, F; Lorriaux, A, 2015) |
| "Calciphylaxis is a complication of chronic kidney disease characterized by necrotic lesion in the skin." | ( Hooman, N; Jahangiri, F; Mehrazma, M; Naghshi-Zadiyan, R, 2015) |
| "Calciphylaxis is associated with a poor prognosis in dialysis patients, and its pathogenesis remains incompletely understood." | ( Bardsley, V; El-Damanawi, R; Fry, AC; Galloway, PA; Hiemstra, TF; Ojha, SK; Pritchard, NR, 2015) |
| "Calciphylaxis is dangerous by its fast progression into tissue necrosis, difficult healing process and a great risk of secondary infection which is the most common cause of death in this condition." | ( Blaštíková, J; Dvořáková, G; Souček, M; Svojanovský, J; Vyskočilová, M, 2015) |
| "Calciphylaxis is a rare disease in which the treatment is basically supportive." | ( Sarkis, E, 2015) |
| "Calciphylaxis is a rare but devastating condition that has continued to challenge the medical community since its early descriptions in the scientific literature many decades ago." | ( Goverman, J; Jackson, VA; Kamdar, MM; Kroshinsky, D; Malhotra, R; Nazarian, RM; Nigwekar, SU; Steele, DJ; Thadhani, RI, 2015) |
| "Calciphylaxis is a painful, debilitating, and premorbid condition, which presents as calcified vasculature and soft tissues." | ( Agarwal, S; Esmonde-White, K; Fagan, S; Goverman, J; Jumlongras, D; Levi, B; Lloyd, WR; Loder, S; Morris, MD; Nigwekar, SU; Olsen, BR, 2015) |
| "Calciphylaxis is characterized by abnormal calcification of vessels and skin; however, its aetiology and pathogenesis remain unclear." | ( Barrett, J; Carter, A; Nunley, J; Ortega-Loayza, AG, 2016) |
| "Calciphylaxis is defined as calcification of the media of small- and medium-sized blood vessels in the dermis and subcutaneous tissue." | ( Jiménez-Gallo, D; Linares-Barrios, M; Ossorio-García, L, 2015) |
| "Calciphylaxis is a syndrome of systemic calcification of the arteries leading to painful tissue necrosis and ulceration." | ( Biswas, A; Tremaine, R; Walsh, NM, 2016) |
| "Calciphylaxis is a small vessel vasculopathy, characterized by medial wall calcification that develops in a few patients with chronic renal failure." | ( Adedjouma, A; Arrestier, R; Audard, V; Bartolucci, P; Bentaarit, B; Boulahia, G; Colin, C; Deux, JF; Dudreuilh, C; Dufresne, R; Grimbert, P; Kofman, T; Lang, P; Leibler, C; Maitre, B; Matignon, M; Remy, P; Sahali, D; Tran Van Nhieu, J, 2016) |
| "Non-uremic calciphylaxis is a severe rare disorder characterized by ischemic necrosis." | ( Alsina, M; Colmenero, J; Guañabens, N; Monegal, A; Peris, P, 2016) |
| "Calciphylaxis is a rare disorder predominantly seen in patients with chronic kidney disease." | ( Bourgeois, P; De Haes, P, 2016) |
| "Calciphylaxis is associated with a high mortality rate." | ( Albright, RC; Bridges, AD; Claus, PL; Davis, MD; Dillon, JJ; El-Azhary, RA; El-Zoghby, ZM; Hickson, LJ; Kumar, R; McBane, RD; McCarthy, JT; McCarthy-Fruin, KA; McEvoy, MT; Patzelt, MT; Pittelkow, MR; Weaver, AL; Wetter, DA; Williams, AW, 2016) |
| "Warfarin-associated calciphylaxis is distinct from classic calciphylaxis in pathogenesis, course, and, particularly, outcome." | ( Bhutani, T; Fox, LP; Kornik, R; Mauro, T; Pincus, LB; Rosenblum, MD; Yu, WY, 2017) |
| "Calciphylaxis is a severe complication of advanced chronic kidney disease (CKD)." | ( Hong, D; Jun, M; Li, G; Peng, T; Wang, L; Wang, Y; Zhuo, L, 2018) |
| "Calciphylaxis is a rare skin disease with high morbidity and mortality that frequently affects patients with renal disease." | ( Dobry, AS; Ko, LN; Kroshinsky, D; Nigwekar, S; Sloan, JM; St John, J, 2018) |
| "Calciphylaxis is a devastating multifactorial disorder of the subcutaneous fat that is known to be associated with hypercoagulability." | ( Chen, TY; El-Azhary, RA; Lehman, JS; Lohse, CM, 2018) |
| "Calciphylaxis is a rare disease with a poor prognostic that mostly occurs in patients with renal failure." | ( Alves, C; Ernandez, T; Stoermann Chopard, C, 2018) |
| "Calciphylaxis is a rare disease characterized by calcification of small- to medium-sized blood vessels in the dermis and subcutaneous fat, resulting in cutaneous necrosis." | ( Bradauskaite, G; Chewaproug, D; Minimo, C; Nseir, V; Pedroza, M; Zaki, R, 2021) |
| "Calciphylaxis is a disease of dermal arteriolar calcification that results in necrosis." | ( Garza-Mayers, AC; Kroshinsky, D; Nigwekar, SU; Shah, R; Sykes, DB, 2018) |
| "Calciphylaxis is a rare, painful, and debilitating disorder of vascular calcification and skin necrosis that typically affects patients with advanced kidney disease." | ( Cipriani, NA; Moy, AP; Nazarian, RM; Nigwekar, SU; Williams, EA, 2019) |
| "Calciphylaxis is a rare and potentially fatal disease that affects the subcutaneous layer of the skin." | ( Riedhammer, MM; Truong, DH; Zinszer, K, 2019) |
| "Calciphylaxis is a rare but life-threatening condition, most commonly affecting patients with stage 4 or 5 chronic kidney disease." | ( Deen, J; Schaider, H, 2019) |
| "Calciphylaxis is an infrequent disease that almost exclusively affects patients with chronic kidney disease, although cases have been observed in patients without renal function impairment." | ( Alvarez, CL; Estifan Ksabji, J; Fernández Cañabate, S; Ortega Valin, L, 2018) |
| "Calciphylaxis is a syndrome of cutaneous ischaemic necrosis and ulceration due to arteriolar calcification with subsequent thrombosis, which rarely presents in patients without terminal kidney disease." | ( Minasyan, A; Sainz-Gaspar, L; Sánchez-Aguilar, MD; Suárez-Peñaranda, JM, 2019) |
| "Calciphylaxis is a complex dermatological lesion of micro vascular calcification that is typically presented as panniculitis with gangrenous painful lesions having uremic and non-uremic causes." | ( Kaklotar, JC; Patel, AD; Patel, DM; Patel, GR; Patel, MM; Patel, MV, 2019) |
| "Non-uremic calciphylaxis is a rare, life-threatening condition characterized clinically by cutaneous necrosis and histologically by calcium deposition in small vessel walls." | ( Cotter, D; Hinds, B; Kusari, A; Paravar, T, 2019) |
| "Calciphylaxis is an uncommon life-threatening systemic disease, mostly occurring in patients with chronic kidney disease and other risk factors." | ( Breznik, V; Burja, S; Ekart, R; Jovic, A; Miljkovic, J; Piko, N, 2019) |
| "Calciphylaxis is a life threatening complication in renal patients." | ( Hoyer, J; Kamalanabhaiah, S; Kortus-Goetze, B; Russ, P; Russwurm, M, 2019) |
| "Calciphylaxis is a cutaneous ischemic infarct caused by total occlusion of blood vessels initiated by vascular calcification." | ( Chang, JJ, 2019) |
| "Calciphylaxis is a disorder of cutaneous microvascular calcification and thrombosis leading to chronic, excruciatingly painful, progressive wounds with a high risk of sepsis and death." | ( Nigwekar, SU; Seethapathy, H, 2019) |
| "Calciphylaxis is a very complicated disease that usually presents in patients with end-stage renal disease (ESRD)." | ( Al-Talib, K; Zuhaili, B, 2019) |
| "Calciphylaxis is a rare disorder of poor prognosis that can lead to intense, painful lesions involving the skin and subcutaneous tissue." | ( Noureddine, L; Seethapathy, H, 2019) |
| "Calciphylaxis is a rare and severe disease that manifests with painful skin ulceration and necrosis." | ( Hamada, T; Honda, H; Iida, A; Kanazawa, N; Mima, Y; Miyazawa, N; Mizobuchi, M; Saito, T; Shikida, Y; Sugiyama, M; Suzuki, T; Wada, Y, 2020) |
| "Calciphylaxis is a rare condition usually seen in patients with end-stage renal disease." | ( Chinnadurai, R; Lowney, AC; Miller, M; Sinha, S, 2020) |
| "Calciphylaxis is a rare thrombotic vasculopathy characterized by high morbidity and mortality." | ( Baker, O; Blum, AE; Chakrala, T; Chand, S; Dobry, AS; François, J; Gabel, CK; Garza-Mayers, AC; Ko, LN; Kroshinsky, D; Nguyen, ED; Nigwekar, SU; Rrapi, R; Shah, R; St John, J, 2021) |
| "Calciphylaxis is a serious condition that often occurs in patients with end-stage renal failure undergoing hemodialysis, with potential comorbidities of hyperparathyroidism and chronic kidney disease (CKD)." | ( Ali, F; Friedman, BJ; Gordon Spratt, E; Matharu, T; Nagesh, RV, 2020) |
| "Calciphylaxis is a rare and severe condition, characterized by calcification and thrombosis of small vessels, mainly affecting the skin." | ( Hamich, S; Lagrange, B; Lavelle, O; Mazereeuw, M; Rakotoson, J; Sanchez, M; Tristani, H, 2020) |
| "Calciphylaxis is a rare, highly morbid pathological syndrome of vascular calcification and tissue necrosis." | ( Coe, S; Cole, W; Yoder, CM, 2020) |
| "Calciphylaxis is a small vessel vasculopathy causing subcutaneous ischemic necrosis." | ( Ghanavatian, S; James, DL; Sadolf, JS, 2021) |
| "Calciphylaxis is a rare but potentially fatal disease commonly occurred in dialysis patients." | ( Liu, B; Liu, H; Liu, Y; Tang, R; Xie, X; Yang, X; Zhang, X, 2021) |
| "Calciphylaxis is a rare life-threatening condition, with calcification of small and medium-sized vessels leading to skin necrosis." | ( Casadesus, D; Schnur, J; Sinawe, H; Yoham, AL, 2021) |
| "Calciphylaxis is a potencially disorder in patients with hyperphosphatemic familial tumoral calcinosis (HFTC)." | ( Gómez, C; Morales, P; Requena, S; Santos-Juanes, J, 2022) |
| "Calciphylaxis is a rare and devastating condition with important systemic ramifications." | ( Chand, S; Kroshinsky, D; Micheletti, R; Ortega-Loayza, AG; Pasieka, HB; Rick, J; Rrapi, R; Shinohara, MM; Strowd, L, 2022) |
| "Calciphylaxis is a life-threatening complication most often associated with chronic kidney disease that occurs as a result of the deposition of calcium in dermal and adipose microvasculature." | ( Aghagoli, G; Gallo Marin, B; Hu, SL; Massoud, CM; Robinson-Bostom, L, 2023) |
| "Calciphylaxis is a rare disease, predominantly in chronic kidney disease (CKD), characterized by high morbidity and mortality." | ( Jiao, Y; Liu, H; Ni, H; Sun, L; Xie, X; Zhang, X; Zhao, Y, 2023) |
| "Calciphylaxis is a rare disease with high mortality mainly involving patients with chronic kidney disease (CKD)." | ( Chitalia, V; Durant, O; Goverman, J; Kalim, S; Kramann, R; Krinsky, S; Kroshinsky, D; Malhotra, CK; Malhotra, R; Mengesha, B; Nazarian, RM; Nigwekar, SU; Portales-Castillo, I; Seethapathy, R; Wen, W, 2023) |
| "Calciphylaxis is a rare disease characterized by calcification of the middle layer of small arteries and arterioles, causing secondary cuta-neous ischemia." | ( Ana, T; Anamá, DP; Carolina, V; Denys, P; Guido, MC; Luis, M; María, D; Paula, E, 2023) |